Sorry, we do not have enough data to show an influence graph for this author.
- Full text PDF available (1)
- This year (1)
- Last 5 years (3)
- Last 10 years (3)
Journals and Conferences
The drug development process is long and expensive. High attrition rates due to safety liabilities observed in the clinic, but that were not identified during nonclinical development, are a major… (More)
Emerging hepatic models for the study of drug-induced toxicity include pluripotent stem cell-derived hepatocyte-like cells (HLCs) and complex hepatocyte-non-parenchymal cellular coculture to mimic… (More)